Investor Notification: Personalis, Inc. ($PSNL) Investors Are Reminded to Contact BFA Law About the Ongoing Investigation into $16.25 per Share Merger DealNewsfile Corp · 1 day ago
PSNL Investigation News: Personalis, Inc. Investors are Notified of the Pending Investigation into Ongoing Merger – Contact BFA Law if You Hold SharesGlobeNewsWire · 2 days ago
Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders?PRNewsWire · 3 days ago
PSNL Securities Notice: Personalis, Inc. Shareholders Are Notified to Contact BFA Law About Its Pending Investigation into the $16.25 per Share Merger DealNewsfile Corp · 3 days ago
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced -- Investors are Alerted to Contact BFA LawGuruFocus · 4 days ago
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA LawBusiness Wire · 4 days agoPersonalis, Inc. operates globally as a specialized cancer genomics firm. The company delivers advanced sequencing and data analysis capabilities, primarily supporting the development of novel cancer treatments and facilitating extensive genetic research initiatives. Central to their offerings is the NeXT Platform, which enables detailed data analysis of tumors and their surrounding immune microenvironments, even from small tissue or plasma samples.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | -$0.26 | -$0.30 | Miss |
| May 7, 2026 | -$0.23 | -$0.29 | Miss |
| Feb 26, 2026 | -$0.31 | -$0.26 | Beat |
| Nov 4, 2025 | -$0.28 | -$0.24 | Beat |
| Aug 5, 2025 | -$0.25 | -$0.23 | Beat |
| May 6, 2025 | -$0.23 | -$0.18 | Beat |